share_log

Reneo Pharmaceuticals Q3 EPS $(0.53) Down From $(0.52) YoY

Benzinga Real-time News ·  Nov 8, 2022 07:43

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.53) per share. This is a 1.92 percent decrease over losses of $(0.52) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment